Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3049% below fair value
$7.17+0.23 (+3.31%)
Close on Nov 13, 2026Market cap $292.05MP/E –Yield –
Orthofix Medical r&d expenses
Research and development expenses are spending on new products and technology.
Orthofix Medical's R&D Expenses for the twelve months ending Sep 30, 2026 was $61.91M, down 10.6% year over year. For fiscal 2025 it was $65.85M, down 10.6% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $80.23M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.85M | -10.6% |
| FY2024 | Dec 31, 2024 | $73.64M | -8.2% |
| FY2023 | Dec 31, 2023 | $80.23M | +63.5% |
| FY2022 | Dec 31, 2022 | $49.07M | -1.1% |
| FY2021 | Dec 31, 2021 | $49.62M | +27.1% |
| FY2020 | Dec 31, 2020 | $39.06M | +12.8% |
| FY2019 | Dec 31, 2019 | $34.64M | +4.3% |
| FY2018 | Dec 31, 2018 | $33.22M | +11.8% |
| FY2017 | Dec 31, 2017 | $29.70M | +3.1% |
| FY2016 | Dec 31, 2016 | $28.80M | +9.1% |
| FY2015 | Dec 31, 2015 | $26.39M | +5.6% |
| FY2014 | Dec 31, 2014 | $24.99M | -6.6% |
| FY2013 | Dec 31, 2013 | $26.77M | -6.3% |
| FY2012 | Dec 31, 2012 | $28.58M | +25.0% |
| FY2011 | Dec 31, 2011 | $22.86M | -18.2% |
| FY2010 | Dec 31, 2010 | $27.96M | -11.1% |
| FY2009 | Dec 31, 2009 | $31.46M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.28M | +3.4% |
| Q2 FY2026 | Jun 30, 2026 | $15.94M | +0.1% |
| Q1 FY2026 | Mar 31, 2026 | $15.32M | -22.5% |
| Q4 FY2025 | Dec 31, 2025 | $15.37M | -18.3% |
| Q3 FY2025 | Sep 30, 2025 | $14.77M | -14.6% |
| Q2 FY2025 | Jun 30, 2025 | $15.93M | -11.7% |
| Q1 FY2025 | Mar 31, 2025 | $19.77M | +1.4% |
| Q4 FY2024 | Dec 31, 2024 | $18.81M | -0.7% |
| Q3 FY2024 | Sep 30, 2024 | $17.29M | -6.8% |
| Q2 FY2024 | Jun 30, 2024 | $18.05M | -7.1% |
| Q1 FY2024 | Mar 31, 2024 | $19.49M | -16.4% |
| Q4 FY2023 | Dec 31, 2023 | $18.94M | +44.0% |
| Q3 FY2023 | Sep 30, 2023 | $18.56M | +55.4% |
| Q2 FY2023 | Jun 30, 2023 | $19.42M | +52.2% |
| Q1 FY2023 | Mar 31, 2023 | $23.31M | +107.9% |
| Q4 FY2022 | Dec 31, 2022 | $13.15M | -0.7% |
| Q3 FY2022 | Sep 30, 2022 | $11.94M | -3.4% |
| Q2 FY2022 | Jun 30, 2022 | $12.76M | -2.8% |
| Q1 FY2022 | Mar 31, 2022 | $11.21M | +2.9% |
| Q4 FY2021 | Dec 31, 2021 | $13.24M | +27.8% |
| Q3 FY2021 | Sep 30, 2021 | $12.36M | +24.1% |
| Q2 FY2021 | Jun 30, 2021 | $13.12M | +49.7% |
| Q1 FY2021 | Mar 31, 2021 | $10.90M | +9.4% |
| Q4 FY2020 | Dec 31, 2020 | $10.37M | +22.7% |
| Q3 FY2020 | Sep 30, 2020 | $9.96M | +24.8% |
| Q2 FY2020 | Jun 30, 2020 | $8.77M | -2.4% |
| Q1 FY2020 | Mar 31, 2020 | $9.96M | +8.0% |
| Q4 FY2019 | Dec 31, 2019 | $8.45M | -3.9% |
| Q3 FY2019 | Sep 30, 2019 | $7.98M | -16.8% |
| Q2 FY2019 | Jun 30, 2019 | $8.98M | +13.8% |
| Q1 FY2019 | Mar 31, 2019 | $9.23M | +33.0% |
| Q4 FY2018 | Dec 31, 2018 | $8.79M | +4.0% |
| Q3 FY2018 | Sep 30, 2018 | $9.60M | +38.4% |
| Q2 FY2018 | Jun 30, 2018 | $7.89M | +14.6% |
| Q1 FY2018 | Mar 31, 2018 | $6.94M | -6.6% |
| Q4 FY2017 | Dec 31, 2017 | $8.45M | +12.6% |
| Q3 FY2017 | Sep 30, 2017 | $6.94M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.51M | – |
See a number that looks wrong?